Profile
Keiji Sawamukai worked as a Principal at Pfizer Inc., Nippon Wellcome Kk, Daiichi Sankyo Co., Ltd., and Sanofi-Aventis Ltd..
Mr. Sawamukai attended the University of Tokyo where he received an undergraduate degree in 1985.
Former positions of Keiji Sawamukai
| Companies | Position | End |
|---|---|---|
| DAIICHI SANKYO CO., LTD. | Corporate Officer/Principal | - |
Sanofi-Aventis Ltd.
 Sanofi-Aventis Ltd. Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Ltd. provides pharmaceutical services. It focuses on cardiovascular medicine, thrombosis, oncology, metabolic disorders and diseases of the central nervous system. The company was founded in December 2004 and is headquartered in Guildford, the United Kingdom. | Corporate Officer/Principal | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
Nippon Wellcome Kk
 Nippon Wellcome Kk Pharmaceuticals: OtherHealth Technology Part of GSK Plc, Nippon Wellcome Kk is a Japanese company that researches, develops, manufactures, and markets pharmaceuticals. The company is located in Japan. Nippon Wellcome Kk was acquired by Glaxo Wellcome Plc on April 01, 1999. | Corporate Officer/Principal | - |
Training of Keiji Sawamukai
| University of Tokyo | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| DAIICHI SANKYO CO., LTD. | Health Technology |
| Private companies | 2 |
|---|---|
Nippon Wellcome Kk
Nippon Wellcome Kk Pharmaceuticals: OtherHealth Technology Part of GSK Plc, Nippon Wellcome Kk is a Japanese company that researches, develops, manufactures, and markets pharmaceuticals. The company is located in Japan. Nippon Wellcome Kk was acquired by Glaxo Wellcome Plc on April 01, 1999. | Health Technology |
Sanofi-Aventis Ltd.
Sanofi-Aventis Ltd. Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Ltd. provides pharmaceutical services. It focuses on cardiovascular medicine, thrombosis, oncology, metabolic disorders and diseases of the central nervous system. The company was founded in December 2004 and is headquartered in Guildford, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Keiji Sawamukai
